Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1390202
European Journal of Endocrinology, Vol 139, Issue 2, 202-206
Copyright © 1998 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kytola, S
Right arrow Articles by Salmela, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kytola, S
Right arrow Articles by Salmela, P

Case Reports

Comparative genomic hybridization studies in tumours from a patient with multiple endocrine neoplasia type 1

S Kytola, MJ Makinen, M Kahkonen, BT Teh, J Leisti, and P Salmela

Department of Clinical Genetics, Oulu University Hospital, Finland.

OBJECTIVE: To identify genetic changes, other than the MEN1 gene, that might be involved in the tumorigenesis and progression of multiple endocrine neoplasia type 1 (MEN1)-related tumours. METHODS: We used comparative genomic hybridization (CGH) and loss of heterozygosity (LOH) to study tumours from various sites in a patient with MEN1. RESULTS: Gain of genetic material was not found. Frequent losses of genetic material were found in chromosomes 1, 4, 5, 6, 9, 11 and 18. Besides the chromosome 11 where the MEN1 gene is located, the other regions are known to harbour important tumour suppressor genes. CONCLUSIONS: These results suggest the involvement of other cancer-related genes in the tumorigenesis and progression of MEN1 tumours that warrant further investigations.


This article has been cited by other articles:


Home page
Cancer Res.Home page
P. C. Scacheri, A. L. Kennedy, K. Chin, M. T. Miller, J. G. Hodgson, J. W. Gray, S. J. Marx, A. M. Spiegel, and F. S. Collins
Pancreatic Insulinomas in Multiple Endocrine Neoplasia, Type I Knockout Mice Can Develop in the Absence of Chromosome Instability or Microsatellite Instability
Cancer Res., October 1, 2004; 64(19): 7039 - 7044.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Marx and L. K. Nieman
Aggressive Pituitary Tumors in MEN1: Do They Refute the Two-Hit Model of Tumorigenesis?
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 453 - 456.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Hessman, B. Skogseid, G. Westin, and G. Åkerström
Multiple Allelic Deletions and Intratumoral Genetic Heterogeneity in MEN1 Pancreatic Tumors
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1355 - 1361.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. D. Pack, L. S. Kirschner, E. Pak, Z. Zhuang, J. A. Carney, and C. A. Stratakis
Genetic and Histologic Studies of Somatomammotropic Pituitary Tumors in Patients with the "Complex of Spotty Skin Pigmentation, Myxomas, Endocrine Overactivity and Schwannomas" (Carney Complex)
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3860 - 3865.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Marx
CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3001 - 3009.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 European Society of Endocrinology.